How should we try and regulate medical cannabis in Europe?
This week we’re joined by Benedikt and Jakob Sons, Co-founders of Cansativa – German GMP and GDP certified cannabis and pharmaceutical wholesalers.
Together, we take a detailed look into the current medical cannabis regulations in Germany, including the differences between federal and state governance, cannabis’ status as both a medical product and narcotic, and we share some thoughts on how this sector should be regulated going forward.
→ View full show notes and summary here: https://www.cannabis-conversation.com/blogs/episode77
Cansativa provides independent market access and extensive warehousing and distribution capacities. Founded in 2017 and headquartered in Moerfelden-Walldorf, Germany, Cansativa is a GMP and GDP certified pharmaceutical company licensed for manufacturing, import and trade in pharmaceuticals as well as trade in controlled substances. Cansativa is committed to the goal of professionalizing the medical cannabis market, eliminating stigmatization surrounding it, and reducing prices for patients. Since the very beginning, Cansativa has operated its own distribution and fulfillment center, and as one of the “first movers” in the industry, it has become one of the largest importers and distributors of medical cannabis in Germany. The company supplies pharmacies and pharmaceutical wholesalers throughout Germany. With the newly obtained manufacturing authorization for both its sites, Cansativa strengthens the supply security of medical cannabis on the German market.
Join Benedikt on LinkedIn: https://www.linkedin.com/in/johann-benedikt-sons-762a28103/
Join Jakob on LinkedIn: https://www.linkedin.com/in/jakob-sons-795087133/
Cansativa Website: https://www.cansativa.de/
Medical cannabis distribution in Germany article from MJBiz: https://mjbizdaily.com/video-inside-look-at-medical-cannabis-distribution-in-germany/
Leave a Reply